GH Research Statistics
Total Valuation
GH Research has a market cap or net worth of $934.16 million. The enterprise value is $668.54 million.
Important Dates
The last earnings date was Thursday, March 5, 2026, before market open.
| Earnings Date | Mar 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GH Research has 62.03 million shares outstanding. The number of shares has increased by 17.33% in one year.
| Current Share Class | 62.03M |
| Shares Outstanding | 62.03M |
| Shares Change (YoY) | +17.33% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 26.78% |
| Owned by Institutions (%) | 38.98% |
| Float | 22.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.35 |
| P/TBV Ratio | 3.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 34.13, with a Debt / Equity ratio of 0.00.
| Current Ratio | 34.13 |
| Quick Ratio | 33.65 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -131.05 |
Financial Efficiency
Return on equity (ROE) is -21.04% and return on invested capital (ROIC) is -16.50%.
| Return on Equity (ROE) | -21.04% |
| Return on Assets (ROA) | -15.92% |
| Return on Invested Capital (ROIC) | -16.50% |
| Return on Capital Employed (ROCE) | -21.68% |
| Weighted Average Cost of Capital (WACC) | 9.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$661,068 |
| Employee Count | 73 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.73% in the last 52 weeks. The beta is 1.00, so GH Research's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | +37.73% |
| 50-Day Moving Average | 15.69 |
| 200-Day Moving Average | 14.13 |
| Relative Strength Index (RSI) | 47.61 |
| Average Volume (20 Days) | 203,403 |
Short Selling Information
The latest short interest is 2.70 million, so 4.36% of the outstanding shares have been sold short.
| Short Interest | 2.70M |
| Short Previous Month | 3.05M |
| Short % of Shares Out | 4.36% |
| Short % of Float | 11.76% |
| Short Ratio (days to cover) | 14.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -60.68M |
| Pretax Income | -48.26M |
| Net Income | -48.26M |
| EBITDA | -60.60M |
| EBIT | -60.68M |
| Earnings Per Share (EPS) | -$0.79 |
Full Income Statement Balance Sheet
The company has $280.71 million in cash and $512,000 in debt, with a net cash position of $280.20 million or $4.52 per share.
| Cash & Cash Equivalents | 280.71M |
| Total Debt | 512,000 |
| Net Cash | 280.20M |
| Net Cash Per Share | $4.52 |
| Equity (Book Value) | 279.70M |
| Book Value Per Share | 4.51 |
| Working Capital | 277.60M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$43.55 million and capital expenditures -$121,000, giving a free cash flow of -$43.67 million.
| Operating Cash Flow | -43.55M |
| Capital Expenditures | -121,000 |
| Free Cash Flow | -43.67M |
| FCF Per Share | -$0.70 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GH Research does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.33% |
| Shareholder Yield | -17.33% |
| Earnings Yield | -5.09% |
| FCF Yield | -4.60% |
Analyst Forecast
The average price target for GH Research is $40.33, which is 167.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.33 |
| Price Target Difference | 167.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |